Skip to main content
Q-Linea logo

Q-Linea — Investor Relations & Filings

Ticker · QLINEA ISIN · SE0011527845 LEI · 549300BXVB4XRM8WSC73 ST Manufacturing
Open in API
Filings indexed 322 across all filing types
Latest filing 2024-04-26 Regulatory Filings
Country SE Sweden
Listing ST QLINEA

About Q-Linea

https://www.qlinea.com/

Q-Linea is an infection diagnostics company that develops and manufactures solutions for infectious diseases, with a primary focus on sepsis. The company's core product is the ASTar instrument, a fully automated, benchtop system that provides rapid phenotypic antimicrobial susceptibility testing (AST) directly from positive blood cultures. The ASTar system is designed to significantly reduce the time to result compared to traditional diagnostic methods, which can take up to 48 hours. By delivering faster results, the technology enables clinicians to make earlier, more informed decisions on appropriate antibiotic treatments for critically ill patients. This capability aims to improve patient outcomes, support antibiotic stewardship, and help combat the development of antimicrobial resistance.

Recent filings

Filing Released Lang Actions
Q-linea får FDA 510(k)-godkännande för ASTar®
Regulatory Filings Classification · 100% confidence The document is a short press release written in Swedish announcing that Q-linea received FDA 510(k) clearance for its ASTar® system, enabling launch in the US. It includes quotes from the CEO, context about sepsis in the US, and contact information. Crucially, the final section lists an 'Bifogade filer' (Attached files) link to the full announcement PDF. Since the document itself is short (2639 chars) and primarily serves to announce the publication of information (the FDA clearance news), it fits the criteria for a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given that this is a specific, material announcement about regulatory approval and market access, it is best classified as a general Regulatory Filing (RNS) as it is not a standard financial report (10-K, IR, ER) or a specific corporate action notice (DIV, CAP, SHA). It is an official regulatory update/announcement.
2024-04-26 Swedish
Annual Report 2023
Annual Report Classification · 100% confidence The document is titled 'Årsredovisning 2023' which translates to 'Annual Report 2023' in Swedish. It contains detailed financial statements including income statement, balance sheet, cash flow statements, notes on accounting principles, management commentary, and audit report sections. The content covers the full fiscal year ending 2023-12-31, with comprehensive financial data and analysis. The length is substantial (15,000 characters), indicating it is the full report rather than an announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K). FY 2023
2024-04-12 Swedish
Annual Report 2023
Annual Report Classification · 98% confidence The document is titled 'Q-LINEA - 2023' and contains extensive content typical of a comprehensive yearly report, including a management report, financial statements (income statement, balance sheet, cash flow statement), accounting principles, audit report, and sustainability information. It covers the full fiscal year ending 2023-12-31, with detailed financial data and narrative sections such as vision, strategy, and market information. The presence of consolidated and parent company financial statements, notes, and an audit report strongly indicates this is a full annual report. The document length is substantial (15,000 characters), and it is not merely an announcement or a brief summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2023
2024-04-12 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 100% confidence The document is a 'Bokslutskommuniké' (Year-end report) for the period 1 January – 31 December 2023. It contains comprehensive financial statements, including income statements, cash flow analysis, and balance sheet summaries, as well as management commentary on business performance, market developments, and future outlook. It is a full financial report for a period shorter than a full fiscal year (in the context of the reporting cycle) and provides substantive financial data, fitting the definition of an Interim/Quarterly Report. FY 2023
2024-02-27 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 100% confidence The document is a 'Year-end report' for the period 1 January–31 December 2023, containing detailed financial results (net sales, operating results, cash flow), management commentary, and operational updates. It is a comprehensive financial report for a period shorter than a full fiscal year (in this case, the fourth quarter and full-year summary), which fits the definition of an Interim/Quarterly Report (IR). It is not an Annual Report (10-K) as it is a quarterly/year-end release, and it is not an Earnings Release (ER) because it provides extensive financial analysis and management discussion beyond just key highlights. FY 2023
2024-02-27 English
Anders Ljunggren takes office as Managing Director of Q-linea AB on 1 March 2024
Board/Management Information Classification · 98% confidence The document explicitly announces a change in senior personnel: 'Anders Ljunggren takes office as Managing Director of Q-linea AB on 1 March 2024'. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in senior management. The text is a press release format, but the core subject matter is management change, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains substantive information about the appointment.
2024-02-01 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.